Ken Igawa

1.3k total citations · 1 hit paper
70 papers, 776 citations indexed

About

Ken Igawa is a scholar working on Dermatology, Rheumatology and Physiology. According to data from OpenAlex, Ken Igawa has authored 70 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Dermatology, 19 papers in Rheumatology and 17 papers in Physiology. Recurrent topics in Ken Igawa's work include Dermatology and Skin Diseases (17 papers), Urticaria and Related Conditions (16 papers) and Allergic Rhinitis and Sensitization (13 papers). Ken Igawa is often cited by papers focused on Dermatology and Skin Diseases (17 papers), Urticaria and Related Conditions (16 papers) and Allergic Rhinitis and Sensitization (13 papers). Ken Igawa collaborates with scholars based in Japan, United States and Germany. Ken Igawa's co-authors include Hiroo Yokozeki, Kiyoshi Nishioka, Takahiro Satoh, Ichiro Katayama, Hiroyuki Murota, Kenji Kabashima, Kristian Reich, Takeshi Matsui, Eric L. Simpson and Ehsanollah Esfandiari and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ken Igawa

64 papers receiving 761 citations

Hit Papers

An anti-OX40 antibody to treat moderate-to-severe atopic ... 2022 2026 2023 2024 2022 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Igawa Japan 15 368 204 189 148 135 70 776
Hideaki Tanizaki Japan 12 349 0.9× 389 1.9× 127 0.7× 88 0.6× 76 0.6× 34 821
Felix Lauffer Germany 18 453 1.2× 310 1.5× 169 0.9× 125 0.8× 127 0.9× 48 757
Beatrice Raone Italy 15 391 1.1× 114 0.6× 123 0.7× 54 0.4× 70 0.5× 41 643
Nuran Allı Türkiye 20 513 1.4× 177 0.9× 86 0.5× 63 0.4× 247 1.8× 78 1.1k
Sayaka Hayashida Japan 13 272 0.7× 149 0.7× 199 1.1× 181 1.2× 91 0.7× 21 646
Rosemarie Watson Ireland 16 319 0.9× 286 1.4× 238 1.3× 110 0.7× 471 3.5× 27 1.1k
Wei‐Sheng Chong Singapore 15 357 1.0× 191 0.9× 50 0.3× 97 0.7× 155 1.1× 55 656
Daniele Torchia Italy 17 381 1.0× 227 1.1× 105 0.6× 71 0.5× 338 2.5× 72 1.0k
Frank Altznauer Switzerland 7 318 0.9× 502 2.5× 267 1.4× 264 1.8× 160 1.2× 8 1.1k
Nihal Mete Türkiye 16 126 0.3× 131 0.6× 252 1.3× 255 1.7× 104 0.8× 57 657

Countries citing papers authored by Ken Igawa

Since Specialization
Citations

This map shows the geographic impact of Ken Igawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Igawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Igawa more than expected).

Fields of papers citing papers by Ken Igawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Igawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Igawa. The network helps show where Ken Igawa may publish in the future.

Co-authorship network of co-authors of Ken Igawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Igawa. A scholar is included among the top collaborators of Ken Igawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Igawa. Ken Igawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Akio, Hidetoshi Takahashi, Ryosuke Shimizu, et al.. (2024). Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J). British Journal of Dermatology. 192(4). 597–610. 2 indexed citations
2.
Guttman‐Yassky, Emma, Ken Igawa, Kenji Kabashima, et al.. (2024). Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study. Dermatology and Therapy. 14(12). 3351–3366.
3.
Tanaka, Akio, Ken Igawa, Hidetoshi Takahashi, et al.. (2024). Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis. Acta Dermato Venereologica. 104. adv34375–adv34375. 7 indexed citations
4.
Guttman‐Yassky, Emma, Eric L. Simpson, Kristian Reich, et al.. (2024). Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study. Advances in Therapy. 41(3). 928–931. 3 indexed citations
5.
Igawa, Ken, et al.. (2023). Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting. SHILAP Revista de lepidopterología. 2(3). 543–548.
6.
Watanabe, Chisato, Shujiro Hayashi, Hitomi Mori, & Ken Igawa. (2023). Erythema nodosum following COVID‐19 vaccination: A case report and literature review. SHILAP Revista de lepidopterología. 2(4). 932–936. 1 indexed citations
7.
Hayashi, Shujiro, et al.. (2023). The Consideration for an Unlikely Culprit Drug (Betahistine) Inducing Toxic Epidermal Necrolysis: A Case Report. Annals of Dermatology. 35(Suppl 1). S135–S136.
8.
Guttman‐Yassky, Emma, Eric L. Simpson, Kristian Reich, et al.. (2022). An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study. The Lancet. 401(10372). 204–214. 99 indexed citations breakdown →
9.
Iijima, Toshie, Shintaro Sakurai, Teruo Jojima, et al.. (2020). Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication. SHILAP Revista de lepidopterología. 8(10). 2007–2012. 3 indexed citations
10.
Hayashi, Shujiro, Satoko Ishikawa, Yoichiro Hamasaki, et al.. (2020). Anti-Inflammatory Effects of Potassium Iodide on SDS-Induced Murine Skin Inflammation. Journal of Investigative Dermatology. 140(10). 2001–2008. 9 indexed citations
11.
Arakawa, Hirokazu, Naoki Shimojo, Norito Katoh, et al.. (2019). Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy. Allergology International. 69(1). 84–90. 11 indexed citations
12.
Hanafusa, Takaaki, et al.. (2016). Bullous erythema ab igne with cutaneous reactive angiomatosis. European Journal of Dermatology. 26(2). 191–192. 3 indexed citations
13.
Igawa, Ken, et al.. (2016). 338 Basophils and mast cells are crucial for reactions due to epicutaneous sensitization to ovalbumin. Journal of Investigative Dermatology. 136(9). S218–S218. 1 indexed citations
15.
Tanemura, Atsushi, Hiroki Higashihara, Yorihisa Kotobuki, et al.. (2012). Arterial Imaging in Digital Gangrenes Associated with Scleroderma-Spectrum Disorders. 2(2). 21–25. 1 indexed citations
16.
Satoh, Takahiro, et al.. (2012). Impaired Expression of Tim-3 on Th17 and Th1 Cells in Psoriasis. Acta Dermato Venereologica. 92(4). 367–371. 40 indexed citations
17.
Hanafusa, Takaaki, Ken Igawa, Shinsuke Takagawa, et al.. (2011). Erythroderma as a paraneoplastic cutaneous disorder in systemic anaplastic large cell lymphoma. Journal of the European Academy of Dermatology and Venereology. 26(6). 710–713. 5 indexed citations
18.
Satoh, Takahiro, Ken Igawa, Kosuke Aritake, et al.. (2009). Dendritic Cells Express Hematopoietic Prostaglandin D Synthase and Function as a Source of Prostaglandin D2 in the Skin. American Journal Of Pathology. 176(1). 227–237. 50 indexed citations
19.
Igawa, Ken, Takahiro Satoh, Mitsuomi Hirashima, & Hiroo Yokozeki. (2006). Regulatory mechanisms of galectin‐9 and eotaxin‐3 synthesis in epidermal keratinocytes: possible involvement of galectin‐9 in dermal eosinophilia of Th1‐polarized skin inflammation. Allergy. 61(12). 1385–1391. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026